Theresa Gray
Foot & Ankle Surgery · Milwaukee, WINPI 1386025377
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.4%), education and travel and lodging — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Arthrex at 39.4% of the total. Reporting peaked in 2022 at $2,226 and has fallen 80.0% since, to $444 in 2025.
Across 73 payments — averaging $51.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$1K
- Johnson & Johnson$482
- Smith+Nephew$353
- AbbVie$260
- Medtronic$176
- Amgen$120
- plus $881 from 25 others
What the payments were for
- Travel & lodging$64217%
- Food & beverage$1,88850%
- Education$1,20032%
- Entertainment$191%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 5 | $1,478 |
| Johnson & Johnson | 3 | $482 |
| Smith+Nephew | 7 | $353 |
| AbbVie(2 entities) | 10 | $260 |
| Medtronic | 2 | $176 |
| Amgen | 1 | $120 |
| ANI Pharmaceuticals, Inc. | 4 | $105 |
| Lilly USA, LLC | 5 | $71 |
| Stryker | 2 | $54 |
| Bayer | 2 | $50 |
| Vanda Pharmaceuticals Inc. | 2 | $50 |
| Novo Nordisk | 3 | $48 |
| Nestle Healthcare Nutrition Inc. | 2 | $46 |
| Treace Medical Concepts, Inc. | 1 | $45 |
| Boehringer Ingelheim | 2 | $41 |
| Organogenesis Inc. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Aimmune Therapeutics, Inc. | 2 | $36 |
| Exact Sciences | 2 | $34 |
| USWM, LLC | 2 | $29 |
| Merck | 2 | $28 |
| Orthofix Medical, Inc. | 1 | $21 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $19 |
| AstraZeneca | 1 | $19 |
| Novartis | 1 | $18 |
| Averitas Pharma Inc. | 1 | $18 |
| KCI USA, Inc. | 1 | $17 |
| Gilead | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Bioventus LLC | 1 | $12 |
| Eisai Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MOTOBAND$408
- INTELLIS ADAPTIVESTIM$162
- KRYSTEXXA$120
- GRAFIX PL$101
- Oasis$101
How this compares
$3,750 in reported general payments places this provider in the 60th percentile of 105 foot & ankle surgery providers in Wisconsin.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 19 | $2,149 |
| Ammonium Lactate | 97 | $1,936 |
| Diclofenac Sodium | 23 | $732 |
| Ketoconazole | 73 | $573 |
| Gabapentin | 52 | $461 |
| Pregabalin | 24 | $452 |
| Terbinafine Hcl | 25 | $268 |
| Amitriptyline Hcl | 23 | $251 |
| Clobetasol Propionate | 11 | $154 |
| Triamcinolone Acetonide | 19 | $94 |
| Ibuprofen | 11 | $33 |
| Tramadol Hcl | 14 | $12 |
| Meloxicam | 12 | $5 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Milwaukee
- David SvedMilwaukee$11K
- Michael IossiMilwaukee$10K
- Isaac YorkMilwaukee$5K
- Priya PatelMilwaukee$4K
- Syeda RoshanMilwaukee$3K
- Margaret KimseyMilwaukee$3K
- Timothy HenkeMilwaukee$3K
- Laith ShamanMilwaukee$2K
- Mexton DeaconMilwaukee$2K
- Mitch HulbertSheboygan$96K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.